Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Anti-Cancer Drugs|July 19, 2013
Clinical relevance and utility of cetuximab-related changes in magnesium and calcium serum levelsSebastian Stintzing, Doris Fischhaber, Charlotte Mook, et al.
BMC Cancer|November 19, 2021
Expression of CIB1 correlates with colorectal liver metastases but not with peritoneal carcinomatosisSven Jacob, Florian Bösch, Markus B Schoenberg, et al.
Journal of Cancer Research and Clinical Oncology|June 21, 2020
Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trialsArndt Stahler, Volker Heinemann, Ingrid Ricard, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 5, 2014
Assessing novel prognostic serum biomarkers in advanced pancreatic cancer: the role of CYFRA 21-1, serum amyloid A, haptoglobin, and 25-OH vitamin D3Michael Haas, Christoph Kern, Stephan Kruger, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 1, 2024
Identification of a gene expression signature associated with brain metastasis in colorectal cancerMarlies Michl, Francesco Taverna, Christine Woischke, et al.
Cellular and Molecular Gastroenterology and Hepatology|October 26, 2021
Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal CancerSophie L Boos, Leon P Loevenich, Sebastian Vosberg, et al.
Clinical Colorectal Cancer|July 1, 2015
Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic FactorsMarlies Michl, Johannes Thurmaier, Gabriele Schubert-Fritschle, et al.
International Journal of Cancer|February 26, 2019
Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT-ME-1 trialJobst Christian von Einem, Christine Guenther, Hans-Dieter Volk, et al.
Oncotarget|November 9, 2017
Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells - TREAT-ME-1 - a phase I, first in human, first in class trialJobst C von Einem, Sylvia Peter, Christine Günther, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|April 13, 2016
Isolated pulmonary metastases define a favorable subgroup in metastatic pancreatic cancerStephan Kruger, Michael Haas, Philipp Johannes Burger, et al.
Pageof 4